Back to catalogue
№ 381 29 filings · 2021-11-22 → 2026-09-02

SOFTWARE CIRCLE PLC

SFT
Technology Share price 18.60p Market cap £73m Overall fit 520 /1000

Partial fit: strong operating leverage and quality VMS portfolio, fair valuation, but AI exposure is defensive rather than a direct beneficiary thesis and leverage is rising. Interesting compounder at a reasonable price, not a high-conviction AI-receiver buy.

Fair value range 18p–25p Mid case · £84m
Absolute upside +15.8% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Clean segmental disclosure of run-rate aEBITDA, oROCD and organic growth
  • Acquired portfolio economics (43% oEBITDA margin, 25% oROCD) are repeatable
  • New Santander RCF makes balance-sheet trajectory legible
Limits the call
  • Fair value very sensitive to applied multiple (12x vs 16x = 18p vs 25p)
  • Valuation assumes continued disciplined M&A pipeline
Methodology

Multiple of run-rate Adjusted EBITDA for VMS compounders

In one line · bull case

A proven, decentralised VMS compounder trading at the bottom of a reasonable fair-value range, with a clear path to Gate 5 (£15m aEBITDA) if M&A discipline continues.

In one line · biggest risk

Rising leverage combined with a defensive-rather-than-offensive AI thesis means a single bad acquisition cycle could compress both earnings and the deserved multiple simultaneously.

Drivers
AI beneficiary 40 /100
VMS defenders talking a thoughtful AI story but no AI-driven revenue line disclosed; indirect beneficiary at best.
Operating leverage 70 /100
76% recurring revenue, 43% oEBITDA margin in acquired portfolio, central costs scaling sub-linearly (24% of oEBITDA vs 33%).
Earnings vs expectations 60 /100
Consistent in-line to modest beats vs management targets; Gate 4 hit ahead of plan.
Growth momentum 72 /100
Revenue +22%, aEBITDA +83%, OCFPS +120% in FY26; three-year revenue CAGR 24%.
Moat 55 /100
Switching costs real at individual VMS level but each business is sub-scale; moat is many small moats rather than one big one.
Earnings quality 55 /100
Strong cash conversion (OCFPS 1.1p) but statutory EPS remains negative due to acquisition-related amortisation.
Management quality 70 /100
Experienced buy-and-build board (ex-Constellation, ex-Judges Scientific), disciplined capital allocation framework, candid disclosure.
Cyclicality 25 /100
Highly recurring subscription software with low churn in mission-critical workflows; defensive.
Leverage 50 /100
Net debt 2.0x aEBITDA, rising; new Santander RCF gives capacity but covenants (4.0x) demand continued delivery.
Value-trap signals · 3
  • Nettl legacy segment in secular decline (-11.5% FY26)
  • Statutory EPS still negative four years into the strategy
  • Share price derated c.22% over the past 12 months despite record results

Software Circle plc (SFT) — Research Note

Executive summary

Software Circle is an AIM-listed serial acquirer of UK/Ireland vertical market software (VMS) businesses, now operating 11 decentralised units across Graphics/Ecommerce, Professional & Financial Services, Health & Social Care, Property and Education. Over the three years to FY26, revenue has compounded 24% CAGR to £22.3m, recurring revenue has gone from 35% to 76% of mix, and Adjusted EBITDA margin has risen from 3% to 26% — the model is clearly working. The key question for valuation today is whether the compounder deserves a 13–15x run-rate aEBITDA multiple given 2.0x net leverage, c.10% organic oEBITDA growth and continued balance-sheet-funded M&A.

Fair value estimate

  • Fair value range: 18p – 25p per share, implying a market cap of £70m – £98m. Midpoint 21.5p / ~£84m.
  • Methodology: multiple of run-rate Adjusted EBITDA for VMS compounders (Constellation/Judges comparable framework), cross-checked against EV/sales.
    • Run-rate aEBITDA at year-end FY26 ≈ £6.8m (per CFO's report in 2026-07 final results).
    • Applied multiple range of 12–16x run-rate aEBITDA → EV range £82m – £109m.
    • Deduct net debt £11.4m → equity £70m – £97m → 18p – 25p.
    • EV/sales cross-check: 3.0–4.0x £25m run-rate = EV £75–100m, broadly consistent.
  • Compared to current market cap of £70.2m (19p), the stock sits at the bottom of my fair-value range: ~13% upside to the midpoint, downside to ~18p.
  • Note: statutory EPS remains negative (-0.21p FY26) because of £4.8m of non-cash amortisation on acquired intangibles; so multiple-based valuation on cash-generative aEBITDA is the right lens rather than P/E.

Sector context

  • Sector: Technology / Software – vertical market software compounder (B2B SaaS roll-up).
  • Quality/growth/leverage vs peers: growth (revenue +22%, aEBITDA +83%) and margin trajectory (26% aEBITDA, OCFPS +120%) are above typical UK listed software peers of similar size; leverage (2.0x) is in line with scaled serial acquirers but higher than most pure-software peers; organic growth of 7% in the acquired portfolio is average for VMS; scale is sub-scale vs listed peers.
  • Listed peers: Judges Scientific (JDG) — closest serial acquirer analogue, scientific instruments rather than software; Diploma (DPLM) — distribution roll-up; direct VMS: Constellation Software/Topicus (TSX, bigger), SDI Group (SDI), Idox (IDOX), Dotdigital. Judges Scientific and Constellation are the clearest spiritual templates the Board explicitly cites.

Investment thesis (3 bullets)

  • Proven VMS flywheel executing to plan. FY26 added 7% organic revenue growth and 23% organic oEBITDA growth in the acquired portfolio, with aEBITDA margin stepping from 17% to 26% and OCFPS doubling to 1.1p. Gate 4 (£5m run-rate aEBITDA) hit a year early; Gate 5 (£15m) is 3-4 years away on current trajectory. The decentralised Constellation-style playbook is being implemented by a board that explicitly includes alumni of Constellation (Maurer) and Judges Scientific (Ormsby) 2024-09 board changes; 2026-07 final results.
  • High-quality recurring revenue, cash-converting. Recurring revenue is 76% of mix (vs 35% three years ago), the acquired portfolio generates oEBITDA margins of 43% ("Rule of 50" quality score), cash from operations was £5.9m on £22.3m revenue, and Operating Return On Capital Deployed is 25%. 2026-07 final results, CFO report.
  • New £25m Santander RCF unlocks the next phase cheaply. The May 2026 refinancing replaces the Shawbrook facility, prices at SONIA + 2.00–3.00% (vs higher Shawbrook terms), extends to 2030, lifts the gross-leverage covenant to 4.0x, and brings £14m of undrawn committed firepower. The business is "approaching the self-funded flywheel" where internally generated cash can fund acquisitions without equity dilution 2026-05 trading update; 2026-07 final results.

Key risks (3 bullets)

  • Leverage trajectory and refinancing dependency. Net debt rose from £2.2m to £11.4m in FY26 (0.7x → 2.0x). Including a further £3.9m of contingent consideration at current performance, effective leverage is higher. The whole model assumes continued successful deployment at disciplined multiples; a cycle of weaker acquisitions or missed earn-out hurdles would quickly stretch 4.0x covenants 2026-07 final results, CFO report.
  • AI thesis is defensive, not offensive. Management's AI narrative is thoughtful but the honest reading is: AI is a risk to VMS which they are managing through workflow embed, proprietary data and regulatory moats. There is no AI-driven revenue line disclosed, no quantified ARPU uplift, no AI-SKU sold today — "systems of action" and "owning the agent" remain forward commentary 2026-07 final results, CEO statement.
  • Nettl legacy drag and organic growth concentration. Group organic revenue declined 1% in FY26 because Nettl Systems (Graphics & Ecommerce, 34% of revenue, originally the whole company) continues to shrink; strip Nettl and acquired portfolio grew 7%, which is decent but not exceptional. If the Group ever stops acquiring, organic growth is in the low single digits 2026-07 final results; 2025-11 interim results.

Operating leverage

Group-level operating leverage is moderate-to-high. The acquired portfolio runs on classic VMS economics — 90%+ recurring revenue in several units, gross margins over 70%, operating EBITDA margins of 43% at a Group level 2026-07 final results, CEO statement and recurring revenue per head run-rating at over £100k (up from £45k three years ago). Central costs of £1.8m (24% of oEBITDA) scale sub-linearly: FY25 central costs rose 20%, operating EBITDA 61%. A 10–20% group revenue beat flowing primarily through the acquired portfolio would plausibly add 25–50% to Adjusted EBITDA, as the £17m of acquired VMS revenue drops to the bottom line at near-70% incremental contribution margin (acquired portfolio incremental: organic revenue up £0.9m, organic oEBITDA up £1.06m in FY26, i.e. >100% incremental margin on the growth cohort 2026-07 final results). The constraint on multiples-of-profit upside is central costs and the drag from Nettl, not platform operating leverage.

Value-trap signals

  • Nettl Systems in secular decline (-11.5% revenue FY26); so far managed through margin discipline, but there's no clear turnaround.
  • Reported EPS remains negative four years into the strategy; the "transition to sustained net profitability" is management's forward view and depends on acquisition cadence slowing or scaling into fixed amortisation.
  • Share price has derated from 25.8p to 19.0p over the past 12 months (−22%) despite record FY26 numbers — suggesting market has concerns I can't fully reconcile (perhaps leverage, small-cap sell-off, or scepticism on run-rate conversion).
  • Otherwise none of the classic value-trap signatures (customer concentration, aggressive accounting, dividend cuts, regulatory threat) are present.

Earnings vs expectations

Management uses "Gate" milestones rather than quarterly guidance. FY25 (May 2025 trading update): guided aEBITDA margin to exceed 15%; delivered 17.3% — modest beat. FY26 (May 2026 pre-close): guided revenue £22.3m, aEBITDA £5.8m, 26% margin against previously communicated "25% target" — in line to modest beat. Gate 4 (£5m run-rate aEBITDA) hit ahead of plan. The acquired portfolio has consistently traded "ahead of valuation expectations" per management, with 20% EBITDA uplift versus underwriting cases 2024-07 final results, CEO statement. Pattern: consistent in-line to modest beats; no profit warnings; no material downgrades.

Conviction

Conviction: 3 — moderate. Anchors: (i) clean disclosure of run-rate aEBITDA, cash conversion and segmental organic growth — the key valuation inputs are well-disclosed; (ii) acquired portfolio metrics (43% oEBITDA margin, 25% oROCD, 7% organic growth) are repeatable benchmarks; (iii) new Santander facility and leverage ceiling make the balance-sheet trajectory legible. Caveats: (i) fair value swings materially with multiple assumption — 12x vs 16x on run-rate aEBITDA is the difference between 18p and 25p, and there is no clean public peer to anchor the right multiple; (ii) the valuation implicitly assumes continued M&A at disciplined multiples — if the pipeline deteriorates, both the run-rate and the deserved multiple compress together.

Filings consulted · 32

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-02Result OF Agm And Board Appointment2026-09-02_9752374_result-of-agm-and-board-appointment.md0.30
  2. 2026-07-23Final Results For The Year Ended 31 March 20262026-07-23_9682986_final-results-for-the-year-ended-31-march-2026.md1.00
  3. 2026-05-2125 0M Revolving Credit Facility Amp Trading Update2026-05-21_9578792_25-0m-revolving-credit-facility-amp-trading-update.md0.85
  4. 2025-11-25Interim Results2025-11-25_9254568_interim-results.md0.77
  5. 2025-10-13Acquisition OF Broker Information Services Limited2025-10-13_9165985_acquisition-of-broker-information-services-limited.md0.49
  6. 2025-09-03Result OF Agm2025-09-03_9087305_result-of-agm.md0.20
  7. 2025-08-08Notice OF Agm2025-08-08_9038915_notice-of-agm.md0.20
  8. 2025-08-05Acquisition OF Artificial Intelligence Finance2025-08-05_9027081_acquisition-of-artificial-intelligence-finance.md0.49
  9. 2025-07-23Final Results For The Year Ended 31 March 20252025-07-23_8993247_final-results-for-the-year-ended-31-march-2025.md0.65
  10. 2025-05-29Trading Update2025-05-29_8901527_trading-update.md0.55
  11. 2025-03-14Acquisition OF Total Drive Software Limited2025-03-14_8779080_acquisition-of-total-drive-software-limited.md0.49
  12. 2024-12-05Interim Results2024-12-05_8591379_interim-results.md0.58
  13. 2024-09-18Board Changes And Trading Update2024-09-18_8422147_board-changes-and-trading-update.md0.38
  14. 2024-07-26Acquisition OF Link Maker Systems Limited2024-07-26_8332294_acquisition-of-link-maker-systems-limited.md0.34
  15. 2024-07-24Final Results2024-07-24_8327062_final-results.md0.45
  16. 2024-05-30Acquisition OF BE The Brand Experience Limited2024-05-30_8230167_acquisition-of-be-the-brand-experience-limited.md0.34
  17. 2024-04-30Pre Close Statement And Trading Update2024-04-30_8163231_pre-close-statement-and-trading-update.md0.38
  18. 2024-02-21Acquisition OF Arc Technology Limited2024-02-21_8047718_acquisition-of-arc-technology-limited.md0.34
  19. 2023-11-27Interim Results2023-11-27_7903648_interim-results.md0.41
  20. 2023-09-26Result OF Agm And Change OF Name And Website2023-09-26_7778773_result-of-agm-and-change-of-name-and-website.md0.15
  21. 2023-07-26Final Results2023-07-26_7654910_final-results.md0.25
  22. 2023-05-03Pre Close Statement And Trading Update2023-05-03_7509680_pre-close-statement-and-trading-update.md0.21
  23. 2023-02-17Acquisition OF Topfloor Systems Limited2023-02-17_7485377_acquisition-of-topfloor-systems-limited.md0.19
  24. 2023-01-18Acquisition OF Care Management Systems Limited2023-01-18_7442811_acquisition-of-care-management-systems-limited.md0.19
  25. 2022-12-07Acquisition OF Watermark Technologies Limited2022-12-07_7358767_acquisition-of-watermark-technologies-limited.md0.19
  26. 2022-11-24Half Year Report2022-11-24_7176858_half-year-report.md0.23
  27. 2022-09-22Acquisition OF Vertical Plus Limited2022-09-22_7065208_acquisition-of-vertical-plus-limited.md0.19
  28. 2022-09-14Result OF Agm2022-09-14_7315719_result-of-agm.md0.07
  29. 2022-07-27Replacement Final Results2022-07-27_7181408_replacement-final-results.md0.25
  30. 2022-07-27Final Results2022-07-27_7179748_final-results.md0.25
  31. 2022-04-06Pre Close Statement And Trading Update2022-04-06_6863503_pre-close-statement-and-trading-update.md0.21
  32. 2021-11-22Half Year Report2021-11-22_6835646_half-year-report.md0.23

This research note was authored by a large language model after reading 29 regulatory filings published between 2021-11-22 and 2026-09-02. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.